Private equity firms Blackstone and TPG have revived their interest in acquiring medical device maker Hologic, according to a person close to the transaction. This renewed interest follows Hologic's rejection of a $16 billion offer from the firms in May.
The re-engagement of these major private equity players signals a potential for a new, possibly higher, take-private offer. Such developments often lead to significant investor attention and can drive stock price movements.
The initial rejection indicated Hologic's board believed the company was undervalued, and renewed discussions suggest a continued belief in the company's strategic value by potential acquirers.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.